PHR — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-09-03

• •Net income was $4.9 million in the six months ended July 31, 2026, as compared to a net loss of $3.3 million in the six months ended July 31, 2025.

• •Adjusted EBITDA was $63.4 million in the six months ended July 31, 2026, as compared to $42.9 million in the six months ended July 31, 2025.

• •Net cash provided by operating activities was $18.3 million for the three months ended July 31, 2026, as compared to $14.8 million for the three months ended July 31, 2025.

• •Net cash provided by operating activities was $42.3 million for the six months ended July 31, 2026, as compared to $29.7 million for the six months ended July 31, 2025.

• •Free cash flow was $13.8 million for the three months ended July 31, 2026, as compared to $9.6 million for the three months ended July 31, 2025.

Text removed vs the prior filing · source: 10-Q · 2026-05-28

• •Net cash provided by operating activities was $23.9 million for the three months ended April 30, 2026, as compared to $14.9 million for the three months ended April 30, 2025.

• •Cash, cash equivalents and restricted cash as of April 30, 2026 was $76.4 million, an increase of $2.6 million as compared to January 31, 2026. As of April 30, 2026, cash, cash equivalents and restricted cash included $1.7 million of long-term restricted cash classified within other long-term asset…

• On March 13, 2026 (the “Refinancing Date”), we and certain of our subsidiaries (collectively, the “Credit Parties”) entered into a Credit Agreement (the “New Capital One Credit Agreement”) providing for a senior secured revolving credit facility (the “New Capital One Credit Facility”) up to an aggre…

• The New Capital One Credit Agreement bears interest at a rate per annum based on SOFR or a Base Rate as specified in the New Capital One Credit Agreement. Swingline loans must be Base Rate loans. We are permitted to repay the Credit Facility, in whole or in part, without penalty or premium, subject …

• We will pay an unused line fee equal to the product of (i) a commitment fee percentage ranging from 0.25% to 0.40% per annum based on the applicable total net leverage ratio and (ii) the unused portion of the revolving commitments under the Credit Facility.

Text added vs the prior filing · source: 10-Q · 2026-09-03

• deteriorate. Due to inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Text added vs the prior filing · source: 10-Q · 2026-09-03

• In addition, as we and the EHR and PM solutions with which we integrate, grow and expand product offerings, the EHR and PM solutions with which we integrate could offer more competitive services or make it more cost

• prohibitive to do business with them. Some of these EHR and PM systems offer, or may begin to offer, services, including patient intake and engagement services, payment processing tools, patient financing options and direct patient communication services, in the same or similar manner as we do. Alth…

• Additionally, our ability to maintain and grow our financing business is in part dependent on our access to capital to provide up-front cash to healthcare providers for eligible patient receivables, which could be obtained from multiple sources, including the securitization of cardholder receivables…

• offer financing solutions with up-front funding to additional healthcare services clients. The existing Securitization Program imposes conditions and limitations on the receivables we are able to fund up-front, including aggregate concentration limits based on certain characteristics of the healthca…

• business, or enforcement and other supervisory actions. Our contracts may not contain limitations of liability, and even where they do, there can be no assurance that limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our privacy an…

Text removed vs the prior filing · source: 10-Q · 2026-05-28

• and would adversely affect our results of operations. Additionally, if we do not maintain our current client network, or if we have to renegotiate existing contracts on terms less favorable to us, our business, financial condition and results of operations may be harmed.

• In addition, as we and the EHR and PM solutions with which we integrate, grow and expand product offerings, the EHR and PM solutions with which we integrate could offer more competitive services or make it more cost prohibitive to do business with them. Some of these EHR and PM systems offer, or may…

• Regulation P and the FTC Safeguards Rule, as well as the FTC’s Identity Theft Red Flags Rule under the Fair Credit Reporting Act, which, among other things, require financial institutions to explain their information sharing practices to their customers, safeguard sensitive data and maintain an iden…

• risks associated with foreign currency fluctuations, our financial condition and operating results could be adversely affected.

• We typically enter into annual contracts for our software solutions with our healthcare services clients, which have a stated initial term of one year and automatically renew for one-year subsequent terms. For most of our software solutions, our clients have no obligation to renew their subscription…

Text added vs the prior filing · source: 10-Q · 2026-09-03

• On July 13, 2026, Chaim Indig, the Chief Executive Officer of the Company, adopted a trading arrangement for the sale of common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Mr. Indig’s Rule 10b5-1 Tradi…

Text removed vs the prior filing · source: 10-Q · 2026-05-28

• None of our directors or “officers,” as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, adopted or terminated a Rule 10b5-1 trading plan or arrangement or a non-Rule 10b5-1 trading plan or arrangement, as defined in Item 408(c) of Regulation S-K, during the fiscal quarter covered…